Oestrogens and Estracyt in Prostate Cancer
- 1 January 1991
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic HyperplasiaNew England Journal of Medicine, 1987
- Steroid‐sensitive proteins, growth hormone and somatomedin C in prostatic cancer: Effects of parenteral and oral estrogen therapyThe Prostate, 1986
- Is Delayed Treatment Justified in Carcinoma of the Prostate?British Journal of Urology, 1985
- Interaction of estramustine phosphate with microtubule‐associated proteinsFEBS Letters, 1985
- An Experimental Approach to the Optimum Oestrogen Dosage in Prostatic CarcinomaBritish Journal of Urology, 1978
- Serum Lipid Levels and Thromboembolic Complications During Estrogen Therapy of Prostatic CancerScandinavian Journal of Urology and Nephrology, 1975
- Treatment of Prostatic Carcinoma with Polyestradiol Phosphate Combined with EthinylestradiolScandinavian Journal of Urology and Nephrology, 1971
- The effect of some stilboestrol compounds on DNA polymerase from human prostatic tissueSteroids, 1970
- The response of prostatic carcinoma to œstrogen treatmentBritish Journal of Surgery, 1953
- THE RESULTS OF DOUBLE CASTRATION IN HYPERTROPHY OF THE PROSTATEAnnals of Surgery, 1895